The Biotech team at ICM is dedicated to boosting the development of new therapies in the field of Neurology and Psychiatry.
Its goal is to design, set up and sustain ambitious and long-term alliances with both academic and industry partners so that the transfer from bench to bedside can be as efficient as possible.
Its mission starts with early detection of research results that could lead to applications, such as new targets, unexpected effects of drug compounds… After having guaranteed sufficient protection with patent applications, financial support is provided for proof of concept studies using Carnot Maturation and NeuroCatalyst funds, and industry partners identified to jointly develop assets. Innovative projects and repositioning of molecules are both valued.
